One session vs multiple sessions of laser for diabetic eye disease
Part of Eyes & vision, Heart & circulation, Hormones & metabolism, Immune system & allergy clinical trials.
This study compares having laser treatment for diabetic eye disease in one session versus spreading it over multiple sessions. The goal is to find out if one approach is better for your eyes and easier for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have type 1 or type 2 diabetes and have been newly diagnosed with a severe form of diabetic eye disease (called proliferative diabetic retinopathy).
- Your vision is at least 20/200 (able to read the big letter on an eye chart).
- The center of your retina (the part that helps you see fine details) has no swelling or cysts.
- You have not had eye surgery in the last 4 months, and you have not had laser or injections for diabetic eye disease in the study eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new laser treatment pattern for people with diabetic eye disease (proliferative diabetic retinopathy) to see if it works better than the standard approach. If you have this condition and want a less invasive treatment option, this study might be a good fit.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
This trial tests a gentle laser treatment (micropulse laser) to reduce swelling in the center of the retina caused by diabetes. The goal is to improve or protect your vision without the need for injections or stronger laser.
This trial tests whether a standard laser treatment for diabetic eye disease (called panretinal photocoagulation) affects the cells on the inside of the cornea, which is the clear front part of the eye. It may help doctors understand if this treatment is safe for your cornea.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
This study looks at how well surgery called vitrectomy works for people with severe nonproliferative diabetic retinopathy (NPDR), a condition where high blood sugar damages the retina. The trial aims to see if this surgery can improve vision and outcomes.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.